Point State Capital LP Seagen Inc. Transaction History

Point State Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $5.35 Million - $7.06 Million	-44,700 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $2.89 Million - $3.87 Million	-20,300 Reduced 31.23%	44,700 $6.91 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $1.85 Million - $2.21 Million	13,000 Added 25.0%	65,000 $11 Million
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $7.02 Million - $8.38 Million	52,000 New	52,000 $8.21 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.